Jefferies Group's LBRX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 12,445 shares of LB Pharmaceuticals Inc (LBRX) worth $277,026, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in LBRX, representing a fresh investment thesis on this company. Largest reduction occurred in Q4 2025, reducing 655 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's LB Pharmaceuticals (LBRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly LB Pharmaceuticals (LBRX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -655 | Reduce 5.00% | 12,445 | $22.26 |
| Q3 2025 | +13,100 | New Buy | 13,100 | $15.79 |
Jefferies Group's LB Pharmaceuticals Investment FAQs
Jefferies Group first purchased LB Pharmaceuticals Inc (LBRX) in Q3 2025, acquiring 13,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held LB Pharmaceuticals Inc (LBRX) for 2 quarters since Q3 2025.
Jefferies Group's largest addition to LB Pharmaceuticals Inc (LBRX) was in Q3 2025, adding 13,100 shares worth $206,849.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 12,445 shares of LB Pharmaceuticals Inc (LBRX), valued at approximately $277,026.
As of the Q4 2025 filing, LB Pharmaceuticals Inc (LBRX) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in LB Pharmaceuticals Inc (LBRX) was 13,100 shares, as reported at the end of Q3 2025.